World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 15 February 2016
Main ID:  NCT02098980
Date of registration: 20/03/2014
Prospective Registration: Yes
Primary sponsor: Supreme Council Of Health, Qatar
Public title: Nutritional Intervention of Type II Diabetes Mellitus by Vitamin D in Qatar
Scientific title: Nutritional Intervention of Type II Diabetes Mellitus by Vitamin D in Qatar
Date of first enrolment: May 2014
Target sample size: 200
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02098980
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)  
Phase:  N/A
Countries of recruitment
Qatar
Contacts
Name:     Mohamed Al-Thani, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Supreme Council of Health
Name:     Amin Jayyousi, M.D.
Address: 
Telephone: 0097455530236
Email: ajayyousi@hamad.qa
Affiliation: 
Name:     Mohamed Al-Thani, Ph.D.
Address: 
Telephone: 97444070100
Email: malthani@sch.gov.qa
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- male or non-pregnant, non-lactating females, aged 18-75

- volunteered to participate by signing the consent form

- BMI ? 40kg/ m2

- serum 25(OH) vitamin D3 (25(OH)D) concentration ?75nmol/L

- fasting serum glucose <7.0 mmol/L

- HOMA insulin resistance index =1.3

- presence of any ONE OR MORE of the following risk factors for type 2 diabetes:

- high BMI (>23)

- high waist circumference according to IDF ethnic specific values for non-
Caucasian (females >80cm; males >90cm)

- family history of diabetes in first-degree relative (parent or sibling)

- previous history of gestational diabetes

- history of high blood glucose, high triglycerides and/or low HDL cholesterol

Exclusion Criteria:

- fasting serum glucose =7.0mmol/L

- history of renal failure or liver disease

- serum urea or creatinine >1.8 times upper limit of normal (ULN)

- serum aspartate or alanine transaminase (AST,ALT) >1.5 times ULN

- current use of drug or drugs to treat diabetes or which influence glucose metabolism

- medical or surgical event requiring hospitalization within 3 months of randomization

- presence of any condition affecting nutrient absorption



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Insulin Resistance
Intervention(s)
Dietary Supplement: Vitamin D
Primary Outcome(s)
Insulin Resistance [Time Frame: 6 months]
Secondary Outcome(s)
Secondary ID(s)
Vitamin D and Diabetes
INDDIQAT Trial
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history